Fig. 1From: Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling studyPlanned study design and sample sizes for the healthy controls and asthmatics. The study was complete after the bronchoscopy visit for the healthy controls and after the 12Â month biomarker visit for the asthmatic participantsBack to article page